Please login to the form below

Not currently logged in
Email:
Password:

Taltz

This page shows the latest Taltz news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Cosentyx scores again in phase 3, strengthens approval claim

Novartis’ Cosentyx scores again in phase 3, strengthens approval claim

However, if Cosentyx can win approval in nr-axSpA – which Taltz also has positive date for – it could continue its lead and bring in more sales growth for Novartis. ... Taltz has also been growing at speed, with first-half sales rising 65% to $606m.

Latest news

More from news
Approximately 8 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...
Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...

Infographics